Schedule of Shareholder Equity Warrants Outstanding (Details) - shares |
9 Months Ended | |
|---|---|---|
Sep. 30, 2025 |
Sep. 30, 2024 |
|
| Equity [Abstract] | ||
| Shares outstanding, beginning | 666,667 | |
| Shares issued | 11,262,808 | 666,667 |
| Shares exercised | (100,000) | |
| Shares Exchanged | (466,666) | |
| Shares expired | ||
| Shares tendered | ||
| Shares outstanding, ending | 11,362,809 | 666,667 |
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments exchanged. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments tendered. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|